Search - tctmd.com

Displaying 1 - 3 of 3

Sort: Relevancy | Date

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

October 12, 2018

Medtronic’s Riptide System Cleared for Thrombus Aspiration in Acute Stroke

News Daily News

Medtronic’s Riptide System Cleared for Thrombus Aspiration in Acute Stroke

January 16, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.